GF Fund Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$165K	Buy	3,401 +1,215	+56%	+$59.1K	﹤0.01%	333
2025 Q1	$74.4K	Buy	2,186 +394	+22%	+$13.4K	﹤0.01%	385
2024 Q4	$70.5K	Buy	+1,792	New	+$70.5K	﹤0.01%	360